|
KMID : 0624620210540010031
|
|
BMB Reports
2021 Volume.54 No. 1 p.31 ~ p.43
|
|
|
The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets
|
|
Kim Chae-Won
Kim Kyun-Do
Lee Heung-Kyu
|
|
|
Abstract
|
|
|
|
Dendritic cells (DC), which consist of several different subsets, specialize in antigen presentation and are critical for mediating the innate and adaptive immune responses. DC subsets can be classified into conventional, plasmacytoid, and monocyte-derived DC in the tumor microenvironment, and each subset plays a different role. Because of the role of intratumoral DCs in initiating antitumor immune responses with tumor-derived antigen presentation to T cells, DCs have been targeted in the treatment of cancer. By regulating the functionality of DCs, several DCbased immunotherapies have been developed, including administration of tumor-derived antigens and DC vaccines. In addition, DCs participate in the mechanisms of classical cancer therapies, such as radiation therapy and chemotherapy. Thus, regulating DCs is also important in improving current cancer therapies. Here, we will discuss the role of each DC subset in antitumor immune responses, and the current status of DC-related cancer therapies.
|
|
|
KEYWORD
|
|
|
Cancer immunology, Cancer therapy, Dendritic cells
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|